Improving Outcomes of T1D Patients With Impaired Awareness of Hypoglycemia: Current Strategies and Future Opportunities
Improving Outcomes of T1D Patients With Impaired Awareness of Hypoglycemia: Current Strategies and Future Opportunities is organized by Prime Education, LLC.
Release Date: February 16, 2023
Expiration Date: February 15, 2024
Description:
For patients with type 1 diabetes (T1D), glycemic monitoring and insulin administration are essential for avoiding hypoglycemia and its life-threatening complications. However, they are especially critical for patients with an attenuated or absent ability to recognize the signs of low blood sugar, a condition known as impaired awareness of hypoglycemia (IAH). Fortunately, research and technological advancements have yielded new opportunities to improve outcomes and quality of life in these patients, including multiple stem cell therapies currently in clinical development for restoring endogenous insulin production. Watch this video to hear leading clinical experts discuss strategies to proactively identify and care for patients with IAH, inclusive of the latest evidence surrounding new and emerging treatments. Don't miss the opportunity to hear firsthand perspectives from a patient with IAH and leave with practical insights to care for patients with this complicating feature of T1D within your own clinical practice.
Listen in as renowned endocrinologists discuss:
• The pathophysiological basis and risk factors for development of IAH in patients with T1D
• Patient perspectives and expert strategies for identifying and improving outcomes for individuals living with IAH
• Emerging therapeutic approaches to restore endogenous insulin production in patients with T1D, including stem cell therapies, which will be illustrated through video animation
Agenda:
• Burden of Severe Hypoglycemia in People with T1D
• Pathogenesis and Risk of Impaired Awareness of Hypoglycemia
• Clinical Strategies to Identify and Manage Patients with Impaired Awareness of Hypoglycemia
• Emerging T1D Treatments Including Stem-cell Based Therapies to Restore Insulin-producing Islet Cells
Learning Objectives:
• Evaluate the burden and challenges of severe hypoglycemia among people with T1D
• Examine the pathogenesis and measurement of impaired awareness of hypoglycemia in patients with T1D
• Apply current evidence to identify patients at risk for severe hypoglycemia and guide individualized glycemic management decisions based on patient characteristics
• Differentiate emerging T1D treatments based on mechanism of action and clinical data related to safety and efficacy